• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Gene . From Delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants

tetano

Editor, Senior Moderator
Gene


. 2022 Jan 3;146134.
doi: 10.1016/j.gene.2021.146134. Online ahead of print.
From Delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants


Vasileios Papanikolaou[SUP] 1 [/SUP], Aris Chrysovergis[SUP] 1 [/SUP], Vasileios Ragos[SUP] 2 [/SUP], Evangelos Tsiambas[SUP] 3 [/SUP], Spyros Katsinis[SUP] 4 [/SUP], Arezina Manoli[SUP] 4 [/SUP], Sotirios Papouliakos[SUP] 5 [/SUP], Dimitrios Roukas[SUP] 6 [/SUP], Stylianos Mastronikolis[SUP] 7 [/SUP], Dimitrios Peschos[SUP] 8 [/SUP], Anna Batistatou[SUP] 9 [/SUP], Efthimios Kyrodimos[SUP] 1 [/SUP], Nicholas Mastronikolis[SUP] 10 [/SUP]



Affiliations

Abstract

Coronavirus-related Severe Acute Respiratory Syndrome (SARS-CoV) in 2002/2003, Middle-East Respiratory Syndrome (MERS-CoV) in 2012/2013, and especially the current 2019/2021 Severe Acute Respiratory Syndrome-2 (SARS-CoV-2) affected negatively the national health systems' endurance worldwide. SARS-Cov-2 virus belongs to lineage b of beta-CoVs demonstrating a strong phylogenetic similarity with BatCoVRaTG13 type. Spike (S) glycoprotein projections -consisting of two subunits S1/S2- provide a unique crown-like formation (corona) on virion's surface. Concerning their functional role, S1 represents the main receptor-binding domain (RBD), whereas S2 is involved in the virus-cell membrane fusion mechanism. On Nov 26[SUP]th[/SUP] 2021, WHO designated the new SARS-CoV-2 strain - named Omicron, from letter ''όμικρον'' in the Greek alphabet - as a variant of concern (B.1.1529 variant). Potentially this new variant is associated with high transmissibility leading to elevated infectivity and probably increased re-infection rates. Its impact on morbidity/mortality remains under investigation. In the current paper, analyzing and comparing the alterations of SARS-CoV-2 S RNA sequences in the defined variants (Alpha to Omicron), we observed some interesting findings regarding the S1-RBD/S2 mutation/deletion equilibrium that maybe affect and modify its activity.

Keywords: COVID-19; RNA; SARS-CoV-2; genome; mutations; variants.
 
Back
Top Bottom